Confocal NL
PrivateLast Round
Early Funding
Oct 17, 2024
Total Funding Raised
$5.72M
Company Overview
Confocal NL is a diagnostic equipment company that develops and produces advanced confocal microscopes for live cell imaging.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Biotech Equipment, Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Confocal NL Comparables
Compare Confocal NL with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genoa Instruments | 88% | |
| CrestOptics | 83% | |
| VisiTech International Ltd. | 82% | |
Confocal NL Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 17, 2024 | ||||
| VC Round | Oct 27, 2022 | ||||
| Convertible Debt | Dec 24, 2021 | ||||
| Early Funding | Sep 11, 2018 | ||||
| Seed | Feb 4, 2016 |
Key People
Founding team and executive leadership
Confocal NL Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rabobank Startup & Scale-up team | Early Funding |
| ROM InWest | Early Funding |
| ECFG | Early Funding, VC Round |
| Nascent Ventures | Early Funding |
| UvA Ventures Holding BV | Seed |
| Innovatiefonds Noord-Holland | Convertible Debt, Early Funding |
| Netherlands Enterprise Agency | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 3, 2025
Christoph van der Reijden appointed as interim Chief Technology Officer.
- Sep 11, 2018
Led by Value Creation Capital.
Confocal NL Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |